
    
      TRIAL DRUG:

      GMRx2: single pill combination of telmisartan/amlodipine/indapamide Dose version 1:
      telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg Dose version 2: telmisartan 20
      mg/amlodipine 2.5 mg/indapamide 1.25 mg I NDICATION: Hypertension

      TRIAL TITLE:

      Efficacy and safety of GMRx2 compared to placebo for the treatment of hypertension.

      OBJECTIVES:

      To investigate the efficacy and safety of GMRx2 compared to placebo for the treatment of
      hypertension.

      INTERVENTION:

      A 2-week single-blind placebo run-in will be followed by a 4-week double-blind period with
      randomization to GMRx2 dose version 1, GMRx2 dose version 2 or placebo.
    
  